February 16,2006

Senator Grassley's Statement for the Record regarding FDA's Approval Process

Please see the following two documents attached as related files:

(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression